Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG.
AIDS. 2012 Mar 13;26(5):599-607.
Related citations
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with a synthetic cohort.
Duclos-Vallée JC, Falissard B, Samuel D.
AIDS. 2011 Aug 24;25(13):1675-6. No abstract available.
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients.
Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M.
AIDS. 2011 Nov 28;25(18):2197-208. Review.
Hepatitis delta in HIV-infected individuals in Europe.
Soriano V, Grint D, d'Arminio Monforte A, Horban A, Leen C, Poveda E, Antunes F, de Wit S, Lundgren J, Rockstroh J, Peters L.
AIDS. 2011 Oct 23;25(16):1987-92.
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.
Lambers FA, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, van der Meer JT, Schinkel J; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group.
AIDS. 2011 Nov 13;25(17):F21-7.
Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient.
van den Berk GE, Arends JE.
AIDS. 2011 Jul 31;25(12):1553-4. No abstract available.
Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa.
Matthews GV, Manzini P, Hu Z, Khabo P, Maja P, Matchaba G, Sangweni P, Metcalf J, Pool N, Orsega S, Emery S; PHIDISA II study team.
AIDS. 2011 Sep 10;25(14):1727-35.
European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients.
García-Álvarez M, Guzmán-Fulgencio M, Berenguer J, Micheloud D, Campos Y, López JC, Cosín J, Miralles P, Alvarez E, Resino S.
AIDS. 2011 Aug 24;25(13):1619-926.
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
Murphy AA, Herrmann E, Osinusi AO, Wu L, Sachau W, Lempicki RA, Yang J, Chung TL, Wood BJ, Haagmans BL, Kottilil S, Polis MA.
AIDS. 2011 Jun 1;25(9):1179-87. Erratum in: AIDS. 2011 Nov 13;25(17):2195. Chung, Tei L [corrected to Chung, Tje L].
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse.
Labarga P, Barreiro P, Mira JA, Vispo E, Rallón N, Neukam K, Camacho A, Caruz A, Rodriguez-Novoa S, Pinilla J, Rivero A, Benito JM, Pineda JA, Soriano V.
AIDS. 2011 May 15;25(8):1131-3.
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.
van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB; CASCADE Collaboration.
AIDS. 2011 May 15;25(8):1083-91.
Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.
Pineda JA, Caruz A, Di Lello FA, Camacho A, Mesa P, Neukam K, Rivero-juárez A, Macías J, Gómez-Mateos J, Rivero A.
AIDS. 2011 Jul 17;25(11):1415-20.
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.
Soriano V, Vispo E, Barreiro P.
AIDS. 2011 Apr 24;25(7):1013-4. No abstract available.
Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration.
Lambers FA, Brinkman K, Schinkel J, Spijkerman IJ, Molenkamp R, Coutinho RA, Prins M, van der Meer JT; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group.
AIDS. 2011 Jun 19;25(10):1333-6.
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
Rallón NI, Soriano V, Naggie S, Restrepo C, Goldstein D, Vispo E, McHutchison J, Benito JM.
AIDS. 2011 May 15;25(8):1025-33.
Error occurred: cannot get document summary
Twice Weekly PegIFN-Alfa 2a And Ribavirin Results In Superior Viral Kinetics In HIV/HCV Co-Infected Patients Compared To Standard Therapy.
A MA, Eva H, O OA, Lynn W, William S, A LR, Jun Y, L CT, J WB, L HB, Shyam K, A PM.
AIDS. 2011 Apr 18. [Epub ahead of print]
Impact of IL28B Polymorphisms on Response to Peginterferon plus Ribavirin in HIV-HCV Coinfected Patients with Prior Non-Response or Relapse.
Labarga P, Barreiro P, Mira JA, Vispo E, Rallón N, Neukam K, Camacho A, Caruz A, Rodriguez-Novoa S, Pinilla J, Rivero A, Pineda JA, Soriano V.
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort.
Cooper C, Kanters S, Klein M, Chaudhury P, Marotta P, Wong P, Kneteman N, Mills EJ.
AIDS. 2011 Mar 27;25(6):777-86. Review.
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
Labarga P, Soriano V, Caruz A, Poveda E, Di Lello F, Hernandez-Quero J, Moreno S, Bernal E, Miró JM, Leal M, Gutierrez F, Portilla J, Pineda JA; CoRIS.
AIDS. 2011 Mar 27;25(6):761-6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on